04259nam 22007092 450 991079046340332120151005020621.01-139-20947-71-316-08917-71-280-48500-01-139-22231-797866135799801-139-21750-X1-139-21442-X1-139-22402-61-139-22059-41-139-02568-6(CKB)2670000000140311(EBL)833425(OCoLC)775869853(SSID)ssj0000613009(PQKBManifestationID)11381771(PQKBTitleCode)TC0000613009(PQKBWorkID)10572448(PQKB)10048116(UkCbUP)CR9781139025683(MiAaPQ)EBC833425(Au-PeEL)EBL833425(CaPaEBR)ebr10533228(CaONFJC)MIL357998(PPN)261333356(EXLCZ)99267000000014031120110218d2012|||| uy| 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierTheory of reflectance and emittance spectroscopy /Bruce Hapke[electronic resource]Second edition.Cambridge :Cambridge University Press,2012.1 online resource (xiii, 513 pages) digital, PDF file(s)Title from publisher's bibliographic system (viewed on 05 Oct 2015).0-521-88349-0 Includes bibliographical references and index.Machine generated contents note: Acknowledgements; 1. Introduction; 2. Electromagnetic wave propagation; 3. The absorption of light; 4. Specular reflection; 5. Single particle scattering: perfect spheres; 6. Single particle scattering: irregular particles; 7. Propagation in a nonuniform medium: the equation of radiative transfer; 8. The bidirectional reflectance of a semi-infinite medium; 9. The opposition effect; 10. A miscellany of bidirectional reflectances and related quantities; 11. Integrated reflectances and planetary photometry; 12. Photometric effects of large scale roughness; 13. Polarization; 14. Reflectance spectroscopy; 15. Thermal emission and emittance spectroscopy; 16. Simultaneous transport of energy by radiation and conduction; Appendix A. A brief review of vector calculus; Appendix B. Functions of a complex variable; Appendix C. The wave equation in spherical coordinates; Appendix D. Fraunhoffer diffraction by a circular hole; Appendix E. Table of symbols; Bibliography; Index.Reflectance and emittance spectroscopy are increasingly important tools in remote sensing and have been employed in most recent planetary spacecraft missions. They are primarily used to measure properties of disordered materials, especially in the interpretation of remote observations of the surfaces of the Earth and other terrestrial planets. This book gives a quantitative treatment of the physics of the interaction of electromagnetic radiation with particulate media, such as powders and soils. Subjects covered include electromagnetic wave propagation, single particle scattering, diffuse reflectance, thermal emittance and polarisation. This new edition has been updated to include a quantitative treatment of the effects of porosity, a detailed discussion of the coherent backscatter opposition effect, a quantitative treatment of simultaneous transport of energy within the medium by conduction and radiation, and lists of relevant databases and software. This is an essential reference for research scientists, engineers and advanced students of planetary remote sensing.Theory of Reflectance & Emittance SpectroscopyReflectance spectroscopyEmission spectroscopyMoonSurfaceSpectraReflectance spectroscopy.Emission spectroscopy.522/.67TEC036000bisacshHapke Bruce1488561UkCbUPUkCbUPBOOK9910790463403321Theory of reflectance and emittance spectroscopy3708816UNINA00845cam0-2200301---450 99000569050040332120250219094503.0000569050FED01000569050(Aleph)000569050FED0100056905019990604d1929----km-y0itay50------baitaITa-------001yyParma nel nome delle sue stradeGiuseppe SittiParmaOfficina grafica Fresching1929230 p., [1] tav. ripieg.25 cmParmaToponomastica914.544Sitti,Giuseppe218552ITUNINARICAUNIMARCBK990005690500403321914.54 SITG 01Ist. Glott.FLFBCFLFBCParma nel nome delle sue strade601870UNINA04443nam 2200469z- 450 991022734610332120210211(CKB)4100000000883872(oapen)https://directory.doabooks.org/handle/20.500.12854/42247(oapen)doab42247(EXLCZ)99410000000088387220202102d2017 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierBiomarkers in Drug HypersensitivityFrontiers Media SA20171 online resource (104 p.)Frontiers Research Topics2-88945-226-3 Biomarkers, especially those based on pharmacogenomics testing, have proved to be extremely useful for type A adverse drug reactions. Clinical practice guidelines based on biomarker testing are presently being developed and updated for type A adverse drug reactions. In contrast, little attention has been paid to the potential use of biomarkers in type B adverse reactions, characterized by the occurrence of reactions not directly related to the pharmacological properties of the drug. Drug-induced hypersensitivity belongs to those type B reactions. Drug-induced hypersensitivity reactions involve complex mechanisms that include, among others, the metabolic activation and haptenization of drug metabolites. Hence, factors that influence the pharmacokinetics of drug and metabolites may contribute to the development of some drug-induced hypersensitivity reactions. This implies that processes such as ADME (absorption, distribution, metabolism and excretion) that are typically involved in type A adverse drug reactions, may have a role in hypersensitivity reactions too. In addition to metabolic activation, several signal transduction pathways participate and modulate the development and the clinical presentation of drug hypersensitivity. The diverse mechanisms underlying such drug-hypersensitivity reactions lead to four major groups of reactions according to the Gell and Coombs classification: immediate, cytotoxic, immune complex and delayed. The enormous complexity of drug-hypersensitivity reactions is a consequence of the variety of mechanisms involved, which may be related, among others, to drug metabolism, generation of antigenic signals, stimulation and maturation of dendritic cells, presentation of haptens and mechanisms of cytotoxicity. In addition, a plethora of possible clinical presentations exists, including urticaria, angioedema, anaphylaxis, cytopenias, nephritis, serum sickness, vasculitis, contact dermatitis, drug rash, eosinophilia and systemic symptoms, Stevens-Johnson syndrome, toxic epidermal necrolysis and acute generalized exanthematous pustulosis. The rapid progress in the field in recent years indicates that the combination of several disciplines is essential to understand the mechanisms involved in this particular, and not completely understood, type of adverse drug reactions. The objective of this Research Topic is to present insights obtained from both basic and clinical scientists, which may include studies related to the identification, validation, refinement and clinical implementation of biomarkers for drug-induced hypersensitivity. The Topic aims to include recent findings related, but not limited to, potential phenomic, genomic, proteomic, metabolomic and signal transduction biomarkers. These biomarkers could eventually be used in clinical practice and/or these might contribute, as a proof of concept, to our understanding of the complex events leading to drug hypersensitivity reactions. In addition the Topic will cover recent developments and methodological advances in the diagnosis, prevention and therapeutic management of drug-induced hypersensitivity.Pharmacologybicsscbiomarkersdrugdrug metabolismgenotypinghaptenizationhypersensitivitymodelsphenotypingPharmacologyEmanuela Corsiniauth1312093Silvia SelinskiauthJose A. G. AgundezauthElena Garcia-MartinauthKlaus GolkaauthBOOK9910227346103321Biomarkers in Drug Hypersensitivity3030677UNINA